Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 103

1.

[Tubulointerstitial Nephritis (Drug-Induced, Inflammatory)].

Strutz F, Grupp C.

Dtsch Med Wochenschr. 2018 Jun;143(11):802-805. doi: 10.1055/a-0511-8458. Epub 2018 May 28. German.

PMID:
29807380
2.

[Autosomal polycystic kidney disease].

Strutz F.

Dtsch Med Wochenschr. 2016 Sep;141(20):1463-1466. Epub 2016 Sep 19. Review. German.

PMID:
27642786
3.

Antifibrotic therapy: is an antioxidative regimen the answer?

Strutz F.

J Am Soc Nephrol. 2014 Jan;25(1):3-5. doi: 10.1681/ASN.2013101034. Epub 2013 Oct 31. No abstract available.

4.

[Phosphate restriction in chronic renal failure - no].

Strutz F.

Dtsch Med Wochenschr. 2013 Sep;138(38):1901. doi: 10.1055/s-0033-1349443. Epub 2013 Sep 10. German. No abstract available.

PMID:
24022456
5.

Antitumoral effects of calcitriol in basal cell carcinomas involve inhibition of hedgehog signaling and induction of vitamin D receptor signaling and differentiation.

Uhmann A, Niemann H, Lammering B, Henkel C, Hess I, Nitzki F, Fritsch A, Prüfer N, Rosenberger A, Dullin C, Schraepler A, Reifenberger J, Schweyer S, Pietsch T, Strutz F, Schulz-Schaeffer W, Hahn H.

Mol Cancer Ther. 2011 Nov;10(11):2179-88. doi: 10.1158/1535-7163.MCT-11-0422. Epub 2011 Aug 30.

6.

Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID).

Tony HP, Burmester G, Schulze-Koops H, Grunke M, Henes J, Kötter I, Haas J, Unger L, Lovric S, Haubitz M, Fischer-Betz R, Chehab G, Rubbert-Roth A, Specker C, Weinerth J, Holle J, Müller-Ladner U, König R, Fiehn C, Burgwinkel P, Budde K, Sörensen H, Meurer M, Aringer M, Kieseier B, Erfurt-Berge C, Sticherling M, Veelken R, Ziemann U, Strutz F, von Wussow P, Meier FM, Hunzelmann N, Schmidt E, Bergner R, Schwarting A, Eming R, Hertl M, Stadler R, Schwarz-Eywill M, Wassenberg S, Fleck M, Metzler C, Zettl U, Westphal J, Heitmann S, Herzog AL, Wiendl H, Jakob W, Schmidt E, Freivogel K, Dörner T; GRAID investigators.

Arthritis Res Ther. 2011 May 13;13(3):R75. doi: 10.1186/ar3337.

7.

Fibrosis and evidence for epithelial-mesenchymal transition in the kidneys of patients with staghorn calculi.

Boonla C, Krieglstein K, Bovornpadungkitti S, Strutz F, Spittau B, Predanon C, Tosukhowong P.

BJU Int. 2011 Oct;108(8):1336-45. doi: 10.1111/j.1464-410X.2010.10074.x. Epub 2011 Mar 16.

8.

The role of bone morphogenetic protein-5 (BMP-5) in human nephrosclerosis.

Bramlage CP, Müller GA, Tampe B, Bevanda J, Maatouk I, Koziolek M, Lange K, Ahrens K, Schmid H, Cohen CD, Bramlage P, Kretzler M, Strutz F.

J Nephrol. 2011 Sep-Oct;24(5):647-55. doi: 10.5301/JN.2011.6330.

PMID:
21319131
9.

Fulminant plasmapheresis-refractory thrombotic microangiopathy associated with advanced gastric cancer.

Vasko R, Koziolek M, Füzesi L, König F, Strutz F, Müller GA.

Ther Apher Dial. 2010 Apr;14(2):222-5. doi: 10.1111/j.1744-9987.2009.00710.x.

PMID:
20438546
10.

Retrospective analysis of long-term lipid apheresis at a single center.

Koziolek MJ, Hennig U, Zapf A, Bramlage C, Grupp C, Armstrong VW, Strutz F, Müller GA.

Ther Apher Dial. 2010 Apr;14(2):143-52. doi: 10.1111/j.1744-9987.2009.00747.x.

PMID:
20438535
11.

Change of heart.

Sivritas SH, Strutz F, Mueller GA.

Am J Med Sci. 2010 Mar;339(3):274. doi: 10.1097/MAJ.0b013e3181b5d072. No abstract available.

PMID:
20051820
12.

Pathogenesis of tubulointerstitial fibrosis in chronic allograft dysfunction.

Strutz F.

Clin Transplant. 2009 Dec;23 Suppl 21:26-32. doi: 10.1111/j.1399-0012.2009.01106.x. Review.

PMID:
19930313
13.

Role of CX3C-chemokine CX3C-L/fractalkine expression in a model of slowly progressive renal failure.

Koziolek MJ, Müller GA, Zapf A, Patschan D, Schmid H, Cohen CD, Koschnick S, Vasko R, Bramlage C, Strutz F.

Nephrol Dial Transplant. 2010 Mar;25(3):684-98. doi: 10.1093/ndt/gfp602. Epub 2009 Nov 24.

PMID:
19934081
14.

The CX(3)C-chemokine fractalkine in kidney diseases.

Koziolek MJ, Vasko R, Bramlage C, Müller GA, Strutz F.

Mini Rev Med Chem. 2009 Sep;9(10):1215-28. Review.

PMID:
19817712
15.

Prenatal dexamethasone exposure does not alter blood pressure and nephron number in the young adult marmoset monkey.

Bramlage CP, Schlumbohm C, Pryce CR, Mirza S, Schnell C, Amann K, Amstrong VW, Eitner F, Zapf A, Feldon J, Oellerich M, Fuchs E, Müller GA, Strutz F.

Hypertension. 2009 Nov;54(5):1115-22. doi: 10.1161/HYPERTENSIONAHA.109.136580. Epub 2009 Sep 21.

PMID:
19770406
16.

Neuropilin-1 and neuropilin-2 are differentially expressed in human proteinuric nephropathies and cytokine-stimulated proximal tubular cells.

Schramek H, Sarközi R, Lauterberg C, Kronbichler A, Pirklbauer M, Albrecht R, Noppert SJ, Perco P, Rudnicki M, Strutz FM, Mayer G.

Lab Invest. 2009 Nov;89(11):1304-16. doi: 10.1038/labinvest.2009.96. Epub 2009 Sep 7.

17.

Renal fibrosis is attenuated by targeted disruption of KCa3.1 potassium channels.

Grgic I, Kiss E, Kaistha BP, Busch C, Kloss M, Sautter J, Müller A, Kaistha A, Schmidt C, Raman G, Wulff H, Strutz F, Gröne HJ, Köhler R, Hoyer J.

Proc Natl Acad Sci U S A. 2009 Aug 25;106(34):14518-23. doi: 10.1073/pnas.0903458106. Epub 2009 Aug 13.

18.

Fulminant polyarteritis nodosa associated with acute myeloid leukaemia resulted in bilateral lower leg amputation.

Buhl T, Bertsch HP, Raab BW, Kaune KM, Vasko R, Strutz F, Schön MP, Lippert U.

Rheumatology (Oxford). 2009 Sep;48(9):1170-2. doi: 10.1093/rheumatology/kep173. Epub 2009 Jun 24. No abstract available.

PMID:
19553374
19.

The role of FGF-2 in renal fibrogenesis.

Strutz F.

Front Biosci (Schol Ed). 2009 Jun 1;1:125-31. Review.

PMID:
19482688
20.

Role of basic fibroblast growth factor (FGF-2) in diabetic nephropathy and mechanisms of its induction by hyperglycemia in human renal fibroblasts.

Vasko R, Koziolek M, Ikehata M, Rastaldi MP, Jung K, Schmid H, Kretzler M, Müller GA, Strutz F.

Am J Physiol Renal Physiol. 2009 Jun;296(6):F1452-63. doi: 10.1152/ajprenal.90352.2008. Epub 2009 Mar 11.

21.

How many different roads may a cell walk down in order to become a fibroblast?

Strutz F.

J Am Soc Nephrol. 2008 Dec;19(12):2246-8. doi: 10.1681/ASN.2008101089. Epub 2008 Nov 19. No abstract available.

22.

Modulatory effects of inflammation and therapy on GDF-5 expression in rheumatoid arthritis synovium.

Bramlage CP, Kaps C, Ungethüm U, Bramlage P, Koziolek M, Wessels J, Krenn V, Pruss A, Müller GA, Strutz F, Burmester GR, Häupl T.

Scand J Rheumatol. 2008 Nov-Dec;37(6):401-9. doi: 10.1080/03009740802120010.

PMID:
18830904
23.

[Progressive renal failure in spontaneous-onset cholesterol crystal embolism].

Neuhoff R, Bramlage C, Gröne E, Strutz F, Koziolek M, Müller GA.

Med Klin (Munich). 2008 Aug 15;103(8):598-601. doi: 10.1007/s00063-008-1096-x. Epub 2008 Sep 21. German.

PMID:
18807234
24.

EMT and proteinuria as progression factors.

Strutz FM.

Kidney Int. 2009 Mar;75(5):475-81. doi: 10.1038/ki.2008.425. Epub 2008 Aug 20. Review.

25.

Chronic course of a hemolytic uremic syndrome caused by a deficiency of factor H-related proteins (CFHR1 and CFHR3).

Koziolek MJ, Zipfel PF, Skerka C, Vasko R, Gröne EF, Müller GA, Strutz F.

Kidney Int. 2008 Aug;74(3):384-8. doi: 10.1038/ki.2008.133. Epub 2008 Apr 30. No abstract available.

26.

Protein adsorption during LDL-apheresis: proteomic analysis.

Dihazi H, Koziolek MJ, Söllner T, Kahler E, Klingel R, Neuhoff R, Strutz F, Mueller GA.

Nephrol Dial Transplant. 2008 Sep;23(9):2925-35. doi: 10.1093/ndt/gfn127. Epub 2008 Apr 8.

PMID:
18398017
27.

The great escape--myofibroblasts in fibrosis and the immune system.

Strutz F.

Nephrol Dial Transplant. 2008 Aug;23(8):2477-9. doi: 10.1093/ndt/gfn171. Epub 2008 Apr 5. No abstract available.

PMID:
18390889
28.

Oncostatin M-induced effects on EMT in human proximal tubular cells: differential role of ERK signaling.

Pollack V, Sarközi R, Banki Z, Feifel E, Wehn S, Gstraunthaler G, Stoiber H, Mayer G, Montesano R, Strutz F, Schramek H.

Am J Physiol Renal Physiol. 2007 Nov;293(5):F1714-26. Epub 2007 Sep 19.

29.
30.

Potential role of fractalkine receptor expression in human renal fibrogenesis.

Koziolek MJ, Schmid H, Cohen CD, Blaschke S, Hemmerlein B, Zapf A, Müller GA, Strutz F.

Kidney Int. 2007 Sep;72(5):599-607. Epub 2007 Jun 20.

31.

Effective treatment of hepatitis C-associated immune-complex nephritis with cryoprecipitate apheresis and antiviral therapy.

Koziolek MJ, Scheel A, Bramlage C, Groene HJ, Mueller GA, Strutz F.

Clin Nephrol. 2007 Apr;67(4):245-9.

PMID:
17474561
32.

Renal fibroblasts and myofibroblasts in chronic kidney disease.

Strutz F, Zeisberg M.

J Am Soc Nephrol. 2006 Nov;17(11):2992-8. Epub 2006 Oct 11. Review. No abstract available.

33.

Renal fibrosis and the origin of the renal fibroblast.

Strutz F, Müller GA.

Nephrol Dial Transplant. 2006 Dec;21(12):3368-70. Epub 2006 Aug 3. Review. No abstract available.

PMID:
16887850
34.

Bioimpedance analysis and intradialytic hypotension in intermittent hemodialysis.

Koziolek MJ, Gauczinski S, Kahler E, Bramlage CP, Scheel AK, Mueller GA, Strutz F.

Clin Nephrol. 2006 Jul;66(1):39-50.

PMID:
16878434
35.

Biological responses to PDGF-BB versus PDGF-DD in human mesangial cells.

van Roeyen CR, Ostendorf T, Denecke B, Bokemeyer D, Behrmann I, Strutz F, Lichenstein HS, LaRochelle WJ, Pena CE, Chaudhuri A, Floege J.

Kidney Int. 2006 Apr;69(8):1393-402.

36.

Decrease in expression of bone morphogenetic proteins 4 and 5 in synovial tissue of patients with osteoarthritis and rheumatoid arthritis.

Bramlage CP, Häupl T, Kaps C, Ungethüm U, Krenn V, Pruss A, Müller GA, Strutz F, Burmester GR.

Arthritis Res Ther. 2006;8(3):R58. Epub 2006 Mar 15.

38.

[Bone morphogenetic proteins in the skeletal system].

Bramlage CP, Häupl T, Kaps C, Bramlage P, Müller GA, Strutz F.

Z Rheumatol. 2005 Sep;64(6):416-22. Review. German.

PMID:
16184350
39.

The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway.

Heeg MH, Koziolek MJ, Vasko R, Schaefer L, Sharma K, Müller GA, Strutz F.

Kidney Int. 2005 Jul;68(1):96-109.

40.

Tubular cell apoptosis and cidofovir-induced acute renal failure.

Ortiz A, Justo P, Sanz A, Melero R, Caramelo C, Guerrero MF, Strutz F, Müller G, Barat A, Egido J.

Antivir Ther. 2005;10(1):185-90.

PMID:
15751777
41.

[Erdheim-Chester disease].

Koziolek MJ, Kunze E, Müller A, Thiem V, Scheel AK, Müller D, Müller GA, Strutz F.

Dtsch Med Wochenschr. 2005 Jan 7;130(1-2):25-8. German.

PMID:
15619170
42.

CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome.

Vielhauer V, Berning E, Eis V, Kretzler M, Segerer S, Strutz F, Horuk R, Gröne HJ, Schlöndorff D, Anders HJ.

Kidney Int. 2004 Dec;66(6):2264-78.

43.

Diagnosis and follow up of aortitis in the elderly.

Scheel AK, Meller J, Vosshenrich R, Kohlhoff E, Siefker U, Müller GA, Strutz F.

Ann Rheum Dis. 2004 Nov;63(11):1507-10.

44.

Transforming growth factor-beta1 stimulates collagen matrix remodeling through increased adhesive and contractive potential by human renal fibroblasts.

Kondo S, Kagami S, Urushihara M, Kitamura A, Shimizu M, Strutz F, Müller GA, Kuroda Y.

Biochim Biophys Acta. 2004 Aug 23;1693(2):91-100.

45.

Benign prostatic hyperplasia (BPH) requiring transurethral resection in freshly transplanted renal allograft recipients.

Koziolek MJ, Wolfram M, Müller GA, Scheel AK, Strutz F, Scheuermann EH, Kramer W.

Clin Nephrol. 2004 Jul;62(1):8-13.

PMID:
15267007
46.

Impact of chronic LDL-apheresis treatment on Achilles tendon affection in patients with severe familial hypercholesterolemia: a clinical and ultrasonographic 3-year follow-up study.

Scheel AK, Schettler V, Koziolek M, Koelling S, Werner C, Müller GA, Strutz F.

Atherosclerosis. 2004 May;174(1):133-9.

PMID:
15135262
47.

Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice.

Anders HJ, Vielhauer V, Eis V, Linde Y, Kretzler M, Perez de Lema G, Strutz F, Bauer S, Rutz M, Wagner H, Gröne HJ, Schlöndorff D.

FASEB J. 2004 Mar;18(3):534-6. Epub 2004 Jan 20.

PMID:
14734643
48.

["Peculiar infection" with fever, splenomegaly and acute kidney failure in a 24-year-old forestry student].

Strutz F, Scheel A, Koziolek M, Kochsiek T, Eiffert H, Müller GA.

Internist (Berl). 2003 Dec;44(12):1575-8. German.

PMID:
14689199
49.

DNA oligonucleotide microarray technology identifies fisp-12 among other potential fibrogenic genes following murine unilateral ureteral obstruction (UUO): modulation during epithelial-mesenchymal transition.

Higgins DF, Lappin DW, Kieran NE, Anders HJ, Watson RW, Strutz F, Schlondorff D, Haase VH, Fitzpatrick JM, Godson C, Brady HR.

Kidney Int. 2003 Dec;64(6):2079-91.

50.

Bone morphogenic protein-7 inhibits progression of chronic renal fibrosis associated with two genetic mouse models.

Zeisberg M, Bottiglio C, Kumar N, Maeshima Y, Strutz F, Müller GA, Kalluri R.

Am J Physiol Renal Physiol. 2003 Dec;285(6):F1060-7. Epub 2003 Aug 12.

Supplemental Content

Loading ...
Support Center